Breaking News, Financial News

Financial Report: ICON 4Q

Business awards for the year were $1.3 billion (+28%) and for the quarter were $261 million.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

ICON 4Q Revenues: $220.1 million (+22%) 4Q Earnings: $21.0 million (+32%) FY Revenues: $865.2 million (+37%) FY Earnings: $78.1 million (+39%) Comments: Business awards for the year were $1.3 billion (+28%) and for the quarter were $261 million. Income from operations was $26.5 million in the quarter (+34%) and $99.5 million for the year (+44%). In the quarter, operating expenses were $4.8 million and capital expenditure was $14.3 million. For the year, operating expenses were $81...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters